Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder with significant dermatological and psychological consequences. While these consequences are widely studied globally, data regarding women in Jordan remain scarce. A descriptive, single-center cross-sectional study was conducted at a tertiary hospital in Jordan. Data were collected from 276 women with PCOS and 80 women of reproductive age without PCOS as a control group. Participants completed the Generalized Anxiety Disorder 7-item (GAD-7) scale, the Patient Health Questionnaire-9 (PHQ-9), the Ferriman–Gallwey score for hirsutism, and the Global Acne Grading System (GAGS). Women with PCOS demonstrated significantly higher self-reported mean scores for anxiety symptoms (10.09 vs. 6.16, p = 0.0001), depressive symptoms (12.07 vs. 8.21, p = 0.001), acne (8.16 vs. 3.55, p = 0.0001), and hirsutism (7.64 vs. 3.59, p = 0.0001) compared to controls. After separate ANCOVA adjustments for age, BMI, and income individually, PCOS status remained a significant predictor of all outcomes after each adjustment (all p < 0.001). Furthermore, depressive symptom scores showed significant positive correlations with self‑reported acne scores ( p = 0.003), self‑reported hirsutism scores ( p < 0.001), and anxiety symptom scores ( p < 0.001). Women with PCOS recruited from a single tertiary hospital in Jordan experienced a considerable psychological and dermatological burden. The association between self-reported cutaneous manifestations and psychological distress underscores the necessity of integrating routine dermatological and mental health assessment into standard PCOS management, alongside culturally tailored awareness campaigns.
No takes yet. Share an insight, caveat, or question.
Qatawneh et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: